Kleine Moleküle & Peptide

NITTP (GMP)

Präkursor für [¹⁸F]FMISO ([¹⁸F]Fluormisonidazol)

1-(2'-Nitro-1'-imidazolyl)-2-O-tetrahydropyranyl-3-O-toluenesulfonyl-propanediol; 3-(2-Nitroimidazol-1-yl)-2-O-tetrahydropyranyl-1-O-toluenesulfonylpropanediol

CA index name: 1H-imidazole-1-propanol, 2-nitro-β-[(tetrahydro-2H-pyran-2-yl)oxy]-, 4-methylbenzenesulfonate (ester)

Qualität

GMP Product

Eigenschaften

Molare Masse 425.46

CAS RN [150196-34-2]

Reinheit ≥ 97 %

  • Yellowish solid

Zertifikate

CoA: appearance, NMR and IR spectra (identity), HPLC (purity), GC (residual solvents), microbiology test

Literatur

Oh S.J. et al. Fully automated synthesis of [¹⁸F]fluoromisonidazole using a conventional [¹⁸F]FDG module. Nucl. Med. Biol. 2005, 32, 899–905.

Lim J.L. et al. An efficient radiosynthesis of [¹⁸F]Fluoromisonidazole. Appl. Radiat. Isot. 1993, 44, 1085–1091.

Martin G.V. et al. Noninvasive detection of hypoxic myocardium using [¹⁸F]Fluoromisonidazole and positron emission tomography. J. Nucl. Med. 1992, 33, 2202–2208.

Rasey J.S. et al. Radiolabeled fluoromisoindazole as an imaging agent for tumor hypoxia. Int. J. Radiat. Oncol. Biol. Phys. 1989, 17, 985–991.

Zur Anfrage hinzufügen

ProduktnummerFüllmengeAnzahl
Produktnummer: 1401Füllmenge: 5 mg
Produktnummer: 1401Füllmenge: 10 mg
Produktnummer: 1401

Verwandte Produkte

Produkt hinzugefügt